Latest Breaking News On - Barbara lindheim - Page 1 : vimarsana.com

Chemomab Therapeutics to Participate in Upcoming Scientific Conferences

TEL AVIV, Israel, May 17, 2024 Chemomab Therapeutics Ltd. , a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today.

United statesHebrew universityBarbara lindheimIlan vakninAmnon peledInternational conventionGordon research conference on chemotactic cytokinesStrategic communicationsChemomab therapeutics ltdGordon research conferenceChemomab corporate developmentHadassah university hospitalChemotactic cytokinesAnnual congressEuropean associationResearch conference

Chemomab Therapeutics to Participate in Upcoming Scientific Conferences - Chemomab Therapeutics (NASDAQ:CMMB)

Chemomab Therapeutics to Participate in Upcoming Scientific Conferences - Chemomab Therapeutics (NASDAQ:CMMB)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesBarbara lindheimStrategic communicationsGordon research conference on chemotactic cytokinesInternational conventionChemomab therapeutics ltdChemomab corporate developmentGordon research conferenceChemotactic cytokinesAnnual congressEuropean associationResearch conferenceSan diego juneOne on partneringPublic relations

Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesMassimo pinzaniChristopher bowlusBarbara lindheimWadi morChemomab therapeutics ltdUc davis healthDigestive healthStrategic communicationsInstitute for liverDevelopment rd expensesEuropean patent officeClinical developmentWebinar highlightsEmerging importanceSurrogate biomarkers

Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update

TEL AVIV, Israel, April 24, 2024 (GLOBE NEWSWIRE) Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need,

Barbara lindheimChemomab therapeutics ltdStrategic communicationsVice presidentPublic relations

Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis

Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomRebeccal rossWadi morBarbara lindheimUniversity of leedsScleroderma programmeArthritis care researchLeeds institute of rheumaticStrategic communicationsChemomab therapeutics ltdLongitudinal studyReal world patient cohort further validatesNovel targetSystemic sclerosisDisease severity acrossVascular manifestations